357 related articles for article (PubMed ID: 35136065)
1. In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue.
Silva-Pinheiro P; Nash PA; Van Haute L; Mutti CD; Turner K; Minczuk M
Nat Commun; 2022 Feb; 13(1):750. PubMed ID: 35136065
[TBL] [Abstract][Full Text] [Related]
2. A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing.
Mok BY; de Moraes MH; Zeng J; Bosch DE; Kotrys AV; Raguram A; Hsu F; Radey MC; Peterson SB; Mootha VK; Mougous JD; Liu DR
Nature; 2020 Jul; 583(7817):631-637. PubMed ID: 32641830
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo.
Zekonyte U; Bacman SR; Smith J; Shoop W; Pereira CV; Tomberlin G; Stewart J; Jantz D; Moraes CT
Nat Commun; 2021 May; 12(1):3210. PubMed ID: 34050192
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases.
Lee H; Lee S; Baek G; Kim A; Kang BC; Seo H; Kim JS
Nat Commun; 2021 Feb; 12(1):1190. PubMed ID: 33608520
[TBL] [Abstract][Full Text] [Related]
5. Enhanced mitochondrial DNA editing in mice using nuclear-exported TALE-linked deaminases and nucleases.
Lee S; Lee H; Baek G; Namgung E; Park JM; Kim S; Hong S; Kim JS
Genome Biol; 2022 Oct; 23(1):211. PubMed ID: 36224582
[TBL] [Abstract][Full Text] [Related]
6. Trends and prospects in mitochondrial genome editing.
Phan HTL; Lee H; Kim K
Exp Mol Med; 2023 May; 55(5):871-878. PubMed ID: 37121968
[TBL] [Abstract][Full Text] [Related]
7. Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo.
Gammage PA; Viscomi C; Simard ML; Costa ASH; Gaude E; Powell CA; Van Haute L; McCann BJ; Rebelo-Guiomar P; Cerutti R; Zhang L; Rebar EJ; Zeviani M; Frezza C; Stewart JB; Minczuk M
Nat Med; 2018 Nov; 24(11):1691-1695. PubMed ID: 30250142
[TBL] [Abstract][Full Text] [Related]
8. Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: a review.
Gao Y; Guo L; Wang F; Wang Y; Li P; Zhang D
Cytotherapy; 2024 Jan; 26(1):11-24. PubMed ID: 37930294
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA.
Mok BY; Kotrys AV; Raguram A; Huang TP; Mootha VK; Liu DR
Nat Biotechnol; 2022 Sep; 40(9):1378-1387. PubMed ID: 35379961
[TBL] [Abstract][Full Text] [Related]
10. Advances in mitochondrial DNA base editing technology.
Song RJ; Han L; Sun HF; Shen B
Yi Chuan; 2023 Aug; 45(8):632-642. PubMed ID: 37609815
[TBL] [Abstract][Full Text] [Related]
11. Enhanced C-To-T and A-To-G Base Editing in Mitochondrial DNA with Engineered DdCBE and TALED.
Wei Y; Jin M; Huang S; Yao F; Ren N; Xu K; Li S; Gao P; Zhou Y; Chen Y; Yang H; Li W; Xu C; Zhang M; Wang X
Adv Sci (Weinh); 2024 Jan; 11(3):e2304113. PubMed ID: 37984866
[TBL] [Abstract][Full Text] [Related]
12. The potential of mitochondrial genome engineering.
Silva-Pinheiro P; Minczuk M
Nat Rev Genet; 2022 Apr; 23(4):199-214. PubMed ID: 34857922
[TBL] [Abstract][Full Text] [Related]
13. Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors.
Lee S; Lee H; Baek G; Kim JS
Nat Biotechnol; 2023 Mar; 41(3):378-386. PubMed ID: 36229610
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial Base Editing: Recent Advances towards Therapeutic Opportunities.
Kar B; Castillo SR; Sabharwal A; Clark KJ; Ekker SC
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982871
[TBL] [Abstract][Full Text] [Related]
15. Gaining Insight into Mitochondrial Genetic Variation and Downstream Pathophysiology: What Can i(PSCs) Do?
Moreira JD; Gopal DM; Kotton DN; Fetterman JL
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828274
[TBL] [Abstract][Full Text] [Related]
16. Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids.
Tolle I; Tiranti V; Prigione A
EMBO Rep; 2023 Apr; 24(4):e55678. PubMed ID: 36876467
[TBL] [Abstract][Full Text] [Related]
17. New potentials of mitochondrial DNA editing.
Wang W; Wang X
Cell Biol Toxicol; 2020 Oct; 36(5):391-393. PubMed ID: 32734362
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering.
Eghbalsaied S; Lawler C; Petersen B; Hajiyev RA; Bischoff SR; Frankenberg S
Gene Ther; 2024 May; 31(5-6):209-223. PubMed ID: 38177342
[TBL] [Abstract][Full Text] [Related]
19. A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibility.
Guo J; Yu W; Li M; Chen H; Liu J; Xue X; Lin J; Huang S; Shu W; Huang X; Liu Z; Wang S; Qiao Y
Mol Cell; 2023 May; 83(10):1710-1724.e7. PubMed ID: 37141888
[TBL] [Abstract][Full Text] [Related]
20. Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases.
Cho SI; Lee S; Mok YG; Lim K; Lee J; Lee JM; Chung E; Kim JS
Cell; 2022 May; 185(10):1764-1776.e12. PubMed ID: 35472302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
